Patients With Asthma Sustain High Patient Activation Levels Over Time: Results of an International Online Survey

Author(s)

Ahmed W1, Alfonso-Cristancho R2, Warner K3, Picton-March A4, Chase K5, Barazetti-Scott J4
1GSK, Huddersfield, UK, 2GSK, Collegeville, PA, USA, 3GSK, Brentford, Middlesex, UK, 4Human8, Manchester, UK, 5Human8, London, UK

OBJECTIVES: Patient activation (measured using Patient Activation Measure questionnaire [PAM]) is a treatable trait in chronic airway diseases. Increased patient activation is associated with improved health outcomes, and reduced disease burden and, subsequently, healthcare resource utilisation. This study aims to highlight changes in patient activation in an international cohort utilising PAM, and provide rationale for said changes.

METHODS: Patients in an international online moderate-to-severe asthma community (n=125; France, Germany, Italy, Spain, Japan, USA) responded to a PAM survey. The survey, conducted in 2023 and 2024, included 13 quantitative statements; results were grouped into activation levels (1-4; higher level=better outcome).

RESULTS: In both years, the overall PAM level was 2.8. Italy, Germany and the USA increased from 2023 to 2024 (2.8→3.0, 2.9→3.0, 3.1→3.2, respectively); Japan remained at 2.1; France and Spain decreased (3.1→2.7, 3.0→2.8, respectively). Responses remained broadly consistent between years, with all countries continuing to agree with most of the condition ownership, medical confidence and proactive/preventive statements. Statements on condition ownership (84-94% agreement) and medical confidence (85-93%) were the strongest both years. However, small declines were recorded for some statements, notably patients’ understanding of prescribed medication (5/6 countries). Scores on ability to proactively manage/prevent health issues were the lowest (77-89%). Japan’s lowest scores related to maintaining lifestyle changes (37-58%). Spain had ≥10% decline across all condition ownership statements. France had ≥10% decrease in 4/5 proactive/preventative statements.

CONCLUSIONS: Access to the online asthma community may have encouraged patients to provide one another with support and additional resources, and to proactively seek information for improved health self-management elsewhere, resulting in high PAM levels in Italy, Germany and the USA. This indicates that access to additional information and support may be important for maintaining patient activation. Further support may be required for patients in Japan, Spain and France to facilitate proactive health self-management and education.

FUNDING: GSK(214851)

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

PCR258

Topic

Patient-Centered Research

Topic Subcategory

Patient Behavior and Incentives

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×